TAK-375: Phase II data; Phase III

In a randomized, double-blind U.S. trial in 375 healthy adults, both 16 and 64 mg doses of TAK-375 produced significantly shorter

Read the full 218 word article

How to gain access

Continue reading with a
two-week free trial.